NEW YORK, Aug. 16 – Bioinformatics company Lion Bioscience of Heidelberg, Germany, said Thursday it had filed for patent protection for a series of lead compounds it had developed.  

The announcement marks Lion’s first such application and comes just 16 months after the company launched its drug discovery efforts.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.